Clinical trial
Fase I Clinical Trial on Natural Killer Cells for COVID-19
NCT04634370 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fase I Clinical Trial on Natural Killer Cells for COVID-19
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- January 2, 2021
- Completion date
- March 30, 2021
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, sars-cov 2